Early identification of cardiovascular risk using genomics and proteomics.
about
Risk assessment in the prevention of cardiovascular disease in low-resource settingsLow-density lipoprotein cholesterol, apolipoprotein B, and risk of coronary heart disease: from familial hyperlipidemia to genomicsTop-down quantitative proteomics identified phosphorylation of cardiac troponin I as a candidate biomarker for chronic heart failurePlasma proteomic analysis of stable coronary artery disease indicates impairment of reverse cholesterol pathwayCardiovascular genomics: a biomarker identification pipelineDevelopment of a multi-institutional cohort to facilitate cardiovascular disease biomarker validation using existing biorepository samples linked to electronic health records.Design of a randomized controlled trial of disclosing genomic risk of coronary heart disease: the Myocardial Infarction Genes (MI-GENES) study.Cardiovascular proteomics: translational studies to develop novel biomarkers in heart failure and left ventricular remodeling.Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.Proteome reference map and regulation network of neonatal rat cardiomyocyte.Genotype-informed estimation of risk of coronary heart disease based on genome-wide association data linked to the electronic medical record.Disease risk prediction with rare and common variants.Building genetic scores to predict risk of complex diseases in humans: is it possible?The relationship between polymorphisms on chromosome 9p21 and age of onset of coronary heart disease in black and white women.Differential impact of race and risk factors on incidence of atrial fibrillation.Calibrating predictive model estimates to support personalized medicine.Comprehensive analysis of protein modifications by top-down mass spectrometryArterial thrombus formation in cardiovascular disease.Recent advances in proteomic technologies applied to cardiovascular disease.Proteomics of plaques and novel sources of potential biomarkers for atherosclerosis.Principles for Developing Patient Avatars in Precision and Systems Medicine.Low holo-transcobalamin levels are prevalent in vegetarians and is associated with coronary artery disease in Indian population.Systems healthcare: a holistic paradigm for tomorrow.Motivation, Perception, and Treatment Beliefs in the Myocardial Infarction Genes (MI-GENES) Randomized Clinical Trial.Nanoparticles for diagnosis and therapy of atherosclerosis and myocardial infarction: evolution toward prospective theranostic approachesAssociation of Interleukin-6 Gene Polymorphism With Angina Pectoris
P2860
Q26744435-2FD9B8C1-CA34-4275-895C-AE4C7EBE3CC1Q26853114-82414255-EEE1-4CDE-8D99-0D9A6DC8ACC7Q28243166-CD0FD7C6-6832-4B7E-9CE6-43495F289F9EQ28397909-C0B93EBC-AE53-47B0-9A6B-07D753757E1FQ28596902-2C080F6E-31D2-4E8A-8312-4D3DEA5D4AA1Q30574994-99E59DD1-3E43-4310-B067-8D64F59A25FDQ30661270-3A4129CB-1C69-4DC5-BE8B-CC22D5265629Q33797033-8A32CA1A-2BF1-4F18-B7B0-D066162DC605Q33972551-2ED8D786-EA8A-49C7-B052-02DFD30C4325Q33992937-1475F7A3-0420-4AD3-B796-EC6E8E80ED88Q34094016-B99A90C8-75F6-45A9-8CB2-77B43AEC6642Q34176843-86C7A668-048A-4B0F-8451-11B7C9F77E7EQ34237579-7744EC6B-550B-4A11-8194-27641A954032Q35006846-8EAC4BD5-B253-4590-87EF-B4EAE2D3064AQ35108134-BC16627A-E022-4A7B-A1EF-E1F06ADA5D7DQ35751188-637498F1-8271-48E5-A1DF-A94B9B708F67Q35873932-F7B1120F-A701-471B-9BCF-54C96CC23E5AQ37897474-92223E7F-63CB-4837-8813-B45A19C92AB9Q38034137-63905DF4-12AE-43F2-AD34-0B6BA0E4C8B8Q38106664-EE8F6562-ADDA-4392-9FB5-4803CBD3FE0AQ40345161-3AB49EDB-C633-4A30-9FA3-C75141AF30AFQ40841199-1AC2D8DF-6253-4D22-B67D-CD91AD387A06Q47281739-DED7D0A8-E4BE-420C-99A0-E50E78B15509Q47350873-46F2DE70-9BE1-4A93-899B-AA5F7C23E5C4Q57116116-A967FF4F-81F9-4D70-AFC4-30657CFEA967Q57556281-1F990FDA-2E1D-4F9D-A9A8-1A8A6CE81444
P2860
Early identification of cardiovascular risk using genomics and proteomics.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Early identification of cardiovascular risk using genomics and proteomics.
@ast
Early identification of cardiovascular risk using genomics and proteomics.
@en
Early identification of cardiovascular risk using genomics and proteomics.
@nl
type
label
Early identification of cardiovascular risk using genomics and proteomics.
@ast
Early identification of cardiovascular risk using genomics and proteomics.
@en
Early identification of cardiovascular risk using genomics and proteomics.
@nl
prefLabel
Early identification of cardiovascular risk using genomics and proteomics.
@ast
Early identification of cardiovascular risk using genomics and proteomics.
@en
Early identification of cardiovascular risk using genomics and proteomics.
@nl
P2860
P356
P1476
Early identification of cardiovascular risk using genomics and proteomics.
@en
P2093
Iftikhar J Kullo
Leslie T Cooper
P2860
P2888
P304
P356
10.1038/NRCARDIO.2010.53
P407
P577
2010-05-04T00:00:00Z
P5875
P6179
1041294660